The global Liquid Biopsy market size in 2022 is 4710.0 million US dollars, and it is expected to be 14738.6 million US dollars by 2029, with a compound annual growth rate of 17.70% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Liquid Biopsy market include Bio-Rad Laboratories (U.S.), Biocept Inc. (U.S.), Guardant Health (U.S.), Illumina Inc. (U.S.), and F. Hoffmann-La Roche Ltd. (Switzerland). The share of the top 3 players in the Liquid Biopsy market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Liquid Biopsy market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Assay Kits accounted for XX% of Liquid Biopsy market in 2022. Instruments share of XX%.
Circulating Tumor Cells accounted for XX% of the Liquid Biopsy market in 2022. Circulating Tumor DNA (ctDNA) accounts for XX%.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Liquid Biopsy Market dynamics, structure by identifying and analyzing the market segments and project the global market size.
In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.
Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
?
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapter 2: Analyzes the Liquid Biopsy manufacturing cost, including raw material analysis, manufacturing cost structure, and industrial chain.
Chapters 3-5: Segmented the global Liquid Biopsy market by type, application and region. Analyze the revenue, sales and price of market segments from different perspectives.
Chapters 6-11: Provide North America, Europe, China, Asia-Pacific, Latin America and Middle East & Africa Liquid Biopsy market type, application, country and players market segmentation data.
Chapter 12: Analyzes the Liquid Biopsy industry chain, including marketing channels, distributors and major downstream buyers.
Chapter 13: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 14: Analyzes the main companies in the Liquid Biopsy industry, including their main businesses, products/services, sales, prices, revenue and gross margin.
Chapter 15: The main points and conclusions of the report.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Nordic
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Player list
Bio-Rad Laboratories (U.S.)
Biocept Inc. (U.S.)
Guardant Health (U.S.)
Illumina Inc. (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Johnson & Johnson (U.S.)
Laboratory Corporation of America Holdings (U.S.)
MDxHealth SA (Belgium)
QIAGEN N.V. (Germany)
Thermo Fisher Scientific Inc. (U.S.)
Types list
Assay Kits
Instruments
Services
Application list
Circulating Tumor Cells
Circulating Tumor DNA (ctDNA)
Cell-free DNA (cfDNA)
Extracellular Vesicles (EVS)
Other Circulating Biomarkers
